Recent Advances in the Treatment of NHL

Learning Objectives

At the conclusion of this session, the participant should be able to:

  • Integrate into professional practice the key updates of the NCCN Guidelines related to NHL
Course summary
Available credit: 
  • 1.25 Case Manager
  • 1.25 Participation
  • 1.25 Nurse
  • 1.25 Pharmacist
  • 1.25 Physician
  • 1.25 Tumor Registrar
Course opens: 
03/16/2013
Course expires: 
04/18/2014
Cost:
$0.00

Jeremy S. Abramson, MD
Massachusetts General Hospital Cancer Center

Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Available Credit

  • 1.25 Case Manager
  • 1.25 Participation
  • 1.25 Nurse
  • 1.25 Pharmacist
  • 1.25 Physician
  • 1.25 Tumor Registrar

Accreditation Period

Course opens: 
03/16/2013
Course expires: 
04/18/2014

Price

Cost:
$0.00
Please login or register to take this course.